Replay
Cancel

Your 25-second video preview has ended.

to continue watching, please Log In or Register:


Log in / Register

Episode 8: Displacement of Subretinal Hemorrhage - A New Technique

Retina Today Journal Club moderator Richard Kaiser, MD, invited Tamer Mahmoud, MD, PhD, to review his study on a novel approach to submacular hemorrhage. In the area of anti-VEGF therapy, visual outcomes are now typically good in cases of age-related macular degeneration, except in the case of a sub retinal hemorrhage.

Dr. Mahmoud accidentally discovered a new technique for treating submacular hemorrhage that includes injecting tissue plasmin activator, bevacizumab (Avastin, Genentech), and an air bubble into the subretinal space, resulting in a superior response by the air bubble covering the submacular space. The results of the pilot study showed that the technique resulted in patients' visual acuity returning to baseline; however, a formal prospective study is needed to further evaluate this novel procedure.


40 / 47 Series: Retina Today Journal Club


More Videos in this Series